- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Correction
- A corrigendum has been published
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Farley, F. W.
- Articles by Elion, E. A.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Farley, F. W.
- Articles by Elion, E. A.
Relative Dependence of Different Outputs of the Saccharomyces cerevisiae Pheromone Response Pathway on the MAP Kinase Fus3p
Francis W. Farleya, Brett Satterberga, Elizabeth J. Goldsmithb, and Elaine A. Elionaa Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115
b Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas 75235
Corresponding author: Elaine A. Elion, Harvard Medical School, Department of Biological Chemistry and Molecular Pharmacology, 240 Longwood Ave., Boston, MA 02115., elion{at}bcmp.med.harvard.edu (E-mail)
Communicating editor: E. W. JONES
| ABSTRACT |
|---|
Fus3p and Kss1p act at the end of a conserved signaling cascade that mediates numerous cellular responses for mating. To determine the role of Fus3p in different outputs, we isolated and characterized a series of partial-function fus3 point mutants for their ability to phosphorylate a substrate (Ste7p), activate Ste12p, undergo G1 arrest, form shmoos, select partners, mate, and recover. All the mutations lie in residues that are conserved among MAP kinases and are predicted to affect either enzyme activity or binding to Ste7p or substrates. The data argue that Fus3p regulates the various outputs assayed through the phosphorylation of multiple substrates. Different levels of Fus3p function are required for individual outputs, with the most function required for shmoo formation, the terminal output. The ability of Fus3p to promote shmoo formation strongly correlates with its ability to promote G1 arrest, suggesting that the two events are coupled. Fus3p promotes recovery through a mechanism that is distinct from its ability to promote G1 arrest and may involve a mechanism that does not require kinase activity. Moreover, catalytically inactive Fus3p inhibits the ability of active Fus3p to activate Ste12p and hastens recovery without blocking G1 arrest or shmoo formation. These results raise the possibility that in the absence of sustained activation of Fus3p, catalytically inactive Fus3p blocks further differentiation by restoring mitotic growth. Finally, suppression analysis argues that Kss1p contributes to the overall pheromone response in a wild-type strain, but that Fus3p is the critical kinase for all of the outputs tested.
HAPLOID Saccharomyces cerevisiae cells (a and
) mate and form diploids through the action of two mitogen-activated protein (MAP) kinases (MAPKs), Fus3p and Kss1p (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The MAP kinases have overlapping and unique functions for mating, although Fus3p plays a more critical role. While a kss1 null does not have obvious mating defects, a fus3 null is partially defective in mating, G1 arrest, and transcription of FUS1 and FUS2 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
-factor has led to the proposal that Kss1p has no role in the mating pathway in the presence of Fus3p (![]()
Analysis of the roles of Fus3p in the pheromone response pathway is complicated by the fact that Fus3p activates Ste12p (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
To analyze the role of Fus3p in the various pheromone responses, we isolated and characterized a series of partial-function fus3 point mutants in a strain lacking KSS1. Our results suggest that Fus3p regulates many outputs through the phosphorylation of multiple substrates, and that Fus3p dosage plays an important role in terminal differentiation. A strong correlation was found between the ability of Fus3p to promote G1 arrest and shmoo formation, suggesting that the two processes may be linked. Suppression analysis argues that Kss1p competes with Fus3p for a subset of substrates in a wild-type strain, but that Fus3p provides essential functions for numerous outputs that cannot be performed by Kss1p. Finally, we show that in a cell containing both Fus3p and Kss1p, catalytically inactive Fus3p preferentially inhibits the ability of active Fus3p to activate Ste12p and promotes recovery from G1 arrest as well as reentry into the mating pathway.
| MATERIALS AND METHODS |
|---|
Media and microbiological techniques:
Media preparation (![]()
![]()
![]()
![]()
or KC8 (![]()
Yeast strain construction:
Yeast strains are listed in Table 1. fus3 mutations (fus3-1, fus3-2, and fus3-201fus3-213) were put into the FUS3 locus by two-step gene replacement using fus3 derivatives of YIp5 (pYBS16, pYBS19, and pYBS81pYBS93). Plasmids were linearized at a PmlI site 3' of FUS3 and then integrated next to fus3::LEU2 in EY966 and EY941. ura3 fus3 recombinants were counterselected with 5-fluoroorotic acid (![]()
|
Plasmid construction:
fus3-8::ADE2 has a 3-kb BglII ADE2 fragment in the BglII site of a fus3 deletion mutant (pYEE97), creating pYEE1122. The fus3-2 URA3 CEN4 plasmid pYBS40 has the 4-kb HindIII fragment of pYBS16 in the HindIII site of YCp50. The same fragment is cloned into the HindIII site of YIp5 and YEp13 to generate pYBS36 and pYBS29, respectively. Integrating plasmids for fus3-201fus3-213 (pYBS81pYBS93) have the BamHI-EcoRI fragment from originally isolated mutants derived from pYEE81 in YIplac211 (![]()
Cloning of fus3-1 and fus3-2:
The fus3-1 and fus3-2 alleles were cloned from EY473 and EY465 (![]()
![]()
![]()
A838, fus3-2 C431
T431). Wild-type FUS3 from EY441 was also sequenced and was found to have five nucleotide differences from the previously sequenced FUS3 gene: one change (C1264
T1264) results in an amino acid change (H334
Y), three are silent (G
A 1194, T
C1212, C
T1264), and one is a deletion 3' to the coding sequence (
13611363).
Hydroxylamine mutagenesis:
Approximately 10 µg of cesium chloride-purified plasmid DNA (pYEE81: FUS3 URA3 CEN4 ARS1) was incubated for 20 hr at 37° in 0.5 ml of neutral hydroxylamine solution (0.44 N NaOH, 5 mM EDTA, 0.07 g/ml hydroxylamine from Sigma, St. Louis). The DNA was precipitated twice using E. coli tRNA as a carrier, washed with 100% ethanol, and then dissolved in 300 µl H2O. A control DNA sample was treated identically using 10 mM Tris-HCl, pH 8.0, 1 mM EDTA. E. coli strain KC8 [RX1486 Mod+(K12) leuB600 trpC9830
lacx74 StrepA LALUK pyrF::Tn5(KanR) his-B463, a gift from K. Struhl] was transformed with aliquots of mutagenized and nonmutagenized DNA, and the frequency of URA3 mutation was determined to be ~1% of the transformants screened. Three pools of ~50,000 transformants each were made.
Isolation of arrest-defective fus3 mutants that mate:
A reconstruction experiment with MATa bar1
fus3
kss1
cells (EY966) containing either wild-type FUS3 or fus3-2 (pYEE81 or pYBS40) was performed to determine the optimal amount of
-factor on the plates. Strain EY966 was then transformed with three pools of hydroxylamine-mutagenized pYEE81. The
-factor-resistant mutants were selected directly on SC-uracil plates with 5 µg of
-factor. A total of 352
-factor-resistant colonies was picked, retested for
-factor resistance, and tested for mating by a qualitative patch mating test with MAT
lys9 and MAT
lys9 fus1
fus2
tester lawns (![]()
-factor resistance and mating.
RNA analysis:
Yeast strains carrying fus3 URA3 CEN4 plasmids were grown at 30° in selective media to an A600 of 0.5 and then split into three aliquots for 0-, 15-, and 120-min
-factor induction time points. Cells were induced in 50 nM
-factor at 30°. Ten milliliters of cells were pelleted and resuspended in 0.5 ml of 25 mM Tris-HCl, pH 8.0, 10 mM EDTA, pH 8.0, 1% SDS, and extracted with an equal volume of 60° water-saturated phenol, incubating at 60° for 30 min with vortexing at 5-min intervals. The aqueous phase was reextracted twice and precipitated with 0.1 volume of 3 M sodium acetate, pH 5.2, and 2 volumes of 100% ethanol at -70° overnight. RNA was pelleted, washed twice with 95% ethanol, and resuspended in 30100 µl of diethyl pyrocarbonate-treated, doubly distilled water. Five micrograms of total RNA was separated in a 1.2% agarose, 20 mM MOPS, pH 7, 5 mM sodium acetate, 10 mM EDTA, 1 M formaldehyde gel, transferred to nitrocellulose, and hybridized as described (![]()
-32P]dATP. FUS1 and BIK1 were detected with the 5.5-kb HindIII-PvuII fragment of pJEF518 (![]()
![]()
Fus1-lacZp assays:
Cells were grown overnight at 30° to an A600 of ~0.3, pelleted, and resuspended at an A600 of 0.3 in two 10-ml aliquots of prewarmed fresh media.
-Factor was added to one of each pair of samples. Cells were shaken at 30° for the indicated length of time, pelleted, and washed once with ice-cold H2O and frozen at -80°. Pellets were partially thawed on ice in 0.25 ml breaking buffer (0.1 M Tris-HCl, pH 8.0, 20% glycerol v/v, 1 mM dithiothreitol), to which 12.5 µl of 40 mM phenylmethylsulfonyl fluoride in 95% ethanol were added. A predetermined amount of acid-washed glass beads (0.450.55 mM diameter, Sigma) was added (to the meniscus), and the samples were vortexed vigorously for four 15-sec pulses, chilling samples intermittently on ice. More breaking buffer was added (0.25 ml), and the samples were vortexed for an additional 15 sec. Samples were then centrifuged for 15 min in a microcentrifuge at 4°, and the supernatant was transferred to a new Eppendorf tube and assayed for total protein using Bio-Rad dye (Bio-Rad, Richmond, CA) and for ß-galactosidase activity as described (![]()
![]()
.
Mating, pheromone sensitivity, and morphogenesis assays:
Four-hour patch matings and quantitative matings, halo assays (using 5 µl of 0.1 mM
-factor dissolved in 90% methanol or dimethylsulfoxide and stored at -20°), and measurement of the percentage of unbudded cells were performed as described (![]()
DNA sequence analysis:
fus3 mutants were sequenced using synthetic oligonucleotides and the Sequenase Kit version 2.0 (United States Biochemical, Cleveland). The entire coding strand of each mutant was sequenced, and the noncoding strand was sequenced across the region containing the mutation. The 26 plasmids consisted of one isolate of fus3-204(G
A 801), 207(G
A 904), 209(C
T 952), 210(G
A 974), 211(G
A 1213), 213 (G
A 352); two isolates of fus3-203(C
T 740), 208(C
T 905), 212(G
A 1216); three isolates of fus3-201(C
T 635), 202(C
T 656), 205(G
A 846); and five isolates of fus3-206(G
A 856). fus3-202, 205, 206, and 212 were each isolated from more than one pool of mutagenized DNA.
Immunoblot analysis of Fus3p and Ste7Mp protein:
Extracts were prepared as described (![]()
![]()
![]()
![]()
| RESULTS |
|---|
Isolation of
-factor-resistant fus3 mutants that mate:
Fus3p regulates G1 arrest, transcriptional activation, and steps leading to the fusion of two cells into a zygote through independent and/or interdependent mechanisms (![]()
-factor and then screened the
-factor-resistant mutants for retention of the ability to mate (MATERIALS AND METHODS). Mating was chosen as a criterion for function because it is dependent upon the activation of the Ste12p transcription factor as well as shmoo formation, partner selection, and cell and nuclear fusion (![]()
![]()
![]()
The fus3 mutants were isolated and analyzed in a strain lacking the KSS1 gene to ensure that all pheromone responses were FUS3 dependent. The BAR1 gene, which encodes an
-factor protease (![]()
-factor needed for selection. Figure 1 shows patch mating and halo assays of representative fus3 mutants and scoring criteria. The mutants fall roughly into three classes of
-factor resistance: as resistant as a fus3
KSS1 strain (e.g., fus3-203, scored as +), slightly more resistant than a fus3
KSS1 strain (e.g., fus3-206, scored as ++), and as resistant as a fus3
kss1
strain (e.g., fus3-205, scored as +++).
|
A summary for all of the fus3 mutants and their amino acid substitutions appears in Table 2, which also includes the original fus3-2 and fus3-1 alleles (![]()
![]()
|
|
The fus3 mutations affect conserved residues implicated in interactions with regulators and substrates:
Strikingly, all but one of the 15 fus3 point mutations isolated in the screen affect residues conserved among MAP kinases (Figure 3). When catalytically inactive and active Erk2p crystal structures (![]()
![]()
|
Seven mutations (fus3-2, fus3-201, fus3-202, fus3-203, fus3-211, fus3-212, and fus3-213) are predicted to affect the enzymatic activity of Fus3p kinase. Four of these mutations [A124V (fus3-201), S131L (fus3-202), D317N (fus3-211), and E318K (fus3-212)] cluster near the hinge between the two domains and may affect either Fus3p catalytic activity or interactions with other proteins. The A124 and S131 mutations are buried and may be more likely to inhibit Fus3p activity, perhaps by affecting domain rotations. In contrast, D317 and E318 are on the surface and may affect interactions with other proteins. The D317 and E318 mutations make Fus3p thermolabile (Table 2). A30T (fus3-213) is at the base of the phosphate anchor (P loop) and may influence ATP binding and overall activity. T56M (fus3-2) is in the C helix, and A159V (fus3-203) is near the Asp-Phe-Gly sequence that interacts with the C helix to maintain the separation between the domains. A159V is adjacent to a key arginine that interacts directly with phosphothreonine 183 in the active form (![]()
![]()
Four mutations (fus3-1, fus3-204, fus3-205, and fus3-206) are predicted to affect interactions with Ste7p and activation of Fus3p. Three of these mutations cluster in and near the phosphorylation lip and, therefore, are quite likely to affect interactions with Ste7p and possible dimerization of Fus3p. Mutations E192K (fus3-1), M194I (fus3-205), and A198T (fus3-206) lie near the surface loop of Erk2p (aa 199205) that interacts with the phosphorylation lip. These mutations could alter the affinity of the lip for Mekp conformational changes associated with Erk2p activation or dimerization (![]()
![]()
![]()
![]()
Four mutations (fus3-207, fus3-208, fus3-209, and fus3-210) are likely to influence the ability of Fus3p to interact with substrates. A214V (fus3-207) and A214T (fus3-208) are in helix F, in the extended substrate binding site identified in cAPK-peptide complexes (![]()
![]()
![]()
The mutant Fus3p proteins have varying defects in hyperphosphorylation of Ste7p:
As an initial indirect assessment of kinase activity, we monitored the ability of the mutant Fus3p proteins to phosphorylate Ste7p in vivo. Fus3p feedback phosphorylates Ste7p (![]()
![]()
-factor, Fus3p multiply phosphorylates the N-terminal regulatory domain of Ste7p, causing it to shift from faster- to slower-migrating species (![]()
![]()
kss1
strain by an undefined mechanism (compare FUS3 KSS1, FUS3 kss1
, fus3
KSS1, and fus3
kss1
strains, Figure 2C; ![]()
Ste7p is hyperphosphorylated to varying degrees in the fus3 kss1
strains, consistent with the isolation of a series of partial-function Fus3p proteins. On the basis of the relative intensities of the hyper- and hypophosphorylated forms of Ste7p, the mutants are classified in Table 2 as wild type (++++), reduced (++), greatly reduced (+), or completely defective (-). Three fus3 kss1
strains (fus3-206, fus3-209, and fus3-213) are wild type for phosphorylation of Ste7p. These mutants may retain wild-type enzymatic activity or have a defect that is not resolvable by using Ste7p as a substrate. Intermediately phosphorylated forms of Ste7p accumulate in most of the mutants, indicating incomplete phosphorylation of Ste7p. Kss1p fully hyperphosphorylates Ste7p in two fus3 mutants tested (fus3-2 KSS1, fus3-205 KSS1; Figure 2C), indicating that the mutant Fus3p proteins present in these strains do not block access of Kss1p to Ste7p.
Dosage response of a FUS3 kss1
strain:
To analyze the mutants phenotypically, we generated an
-factor dosage response curve for transcriptional activation, G1 arrest, and morphogenesis in a control FUS3 kss1
strain. Transcription was monitored by both Northern blot analysis of FUS1 expression and a FUS1-lacZ fusion gene (![]()
![]()
![]()
The FUS3 kss1
strain has a different dosage response curve for each output across the
-factor concentration range that brackets the conditions used in our experiments (Figure 4). Northern blot analysis shows that expression of the FUS1 gene is maximal at 5 nM
-factor after either 15 or 60 min of induction, while FUS1-lacZ expression is only ~65% maximal by 10 nM and ~90% maximal at 25 nM. This difference may be caused by posttranscriptional events that must occur to generate the Fus1-ß-galactosidase fusion protein. G1 arrest does not occur at all at 10 nM
-factor, but is ~85% maximal at 17.5 nM
-factor. The pattern of FUS1-lacZ expression across this range of
-factor concentrations indicates that a proper dosage response is occurring despite the absence of G1 arrest. Cell morphogenesis and shmoo formation only reach ~80 and ~65% maximal levels, respectively, at 50 nM
-factor. Thus, transcription requires the least amount of signaling, G1 arrest requires more, and shmoo formation requires the most signaling. These results are consistent with those of ![]()
-factor was needed for agglutination, G1 arrest, and shmoo formation in a BAR1 strain that is presumably FUS3 and KSS1.
|
Increasing Fus3p function is required for transcriptional activation, G1 arrest, and shmoo formation:
To determine whether increasing Fus3p function might be a determinant for the strength of the different outputs, we measured the relative abilities of the fus3 kss1
strains to transcribe the FUS1 gene (Figure 5; Table 3), arrest in G1 phase (Table 4), enlarge, and form shmoos (Table 5) in the presence of
-factor. A summary of these findings is in Table 2. Transcriptional induction of FUS1, a rapid response, was measured by Northern blot analysis after incubating the cells for 15 and 120 min in a saturating concentration of
-factor (50 nM). G1 arrest was monitored after a 3-hr incubation in 25 nM
-factor (the minimal concentration that confers maximal arrest and a length of time that enables all the cells within a cell cycle to arrest), and shmoo formation was measured after a 3-hr incubation in 50 nM
-factor (the slowest response requiring the most
-factor).
|
|
|
|
Overall, the fus3 kss1
strains have a wide range of output capabilities. They exhibit a ninefold range of FUS1 transcription (11102% wild type), with three of the mutants (fus3-204, fus3-209, and fus3-213) having essentially wild-type levels of transcription (87, 95, and 102%, respectively). They also exhibit a broad spectrum of G1 arrest defects, ranging from little or no arrest defect (fus3-203, fus3-204, fus3-206, fus3-208, fus3-209, and fus3-213) to approximately as defective as a fus3
kss1
double-null mutant (fus3-210, fus3-211, and fus3R42R43). The fus3 kss1
strains are, on average, more severely defective in shmoo formation than the other outputs. Although most strains are able to undergo some morphogenesis (tallied as cell enlargement without an obvious projection), few are able to form complete projections (tallied as shmoo + multishmoo). As expected from the design of our screen, none of the point mutants are as defective as the catalytically inactive fus3R42R43 mutant, which expresses 0.3% wild-type levels of FUS1-lacZ and does not undergo G1 arrest or shmoo formation. None of the mutants display a complete uncoupling of G1 arrest and transcriptional activation (i.e., no G1 arrest with maximal transcription), although our screen allowed for the isolation of such a class of mutants.
We looked for correlations among the various mutants for relative amounts of FUS1 transcription, G1 arrest, morphogenesis, and shmoo formation (Figure 6, AC). Simplest best-fitting curves were computer generated using subsets of mutants and the FUS3 kss1
and fus3
kss1
strains (shown as circles in all the graphs). Mutants that fall near the curve but do not define it are indicated as open triangles. Mutants that appear to be outliers from the curves are indicated as solid triangles. In many instances, the level of FUS1 transcription roughly correlates with the level of G1 arrest, morphogenesis, and shmoo formation, which is consistent with the fact that activation of Ste12p is required for the expression of a variety of genes that are required for all the outputs. Mutants with lower levels of transcription are more defective in G1 arrest, morphogenesis, and shmoo formation, while mutants with high levels of transcription are most efficient for all the outputs. These correlations are more clearly revealed by the mutants predicted to have reduced Fus3 kinase activity rather than by the mutants predicted to have defects in substrate interactions. Mutants with a greater capacity to undergo G1 arrest are also better able to enlarge and form shmoos (Figure 6D and Figure E). Collectively, this analysis argues that increasing Fus3 function is required for transcriptional activation, G1 arrest, morphogenesis, and shmoo formation, respectively.
|
The ability to undergo G1 arrest, undergo morphogenesis, and form shmoos does not strictly correlate with the ability to activate Ste12p:
Next, we used the same comparative analysis to ask how likely it is that Fus3p phosphorylates only one substrate (such as Ste12p) for all of the responses. If this were the case, then one might imagine that a strict correlation should be found among the various outputs, and that the relative strengths of these outputs might also align with the dosage response curve shown in Figure 4. By contrast, a lack of correlation might be expected if it is necessary to phosphorylate more than one substrate, and if the mutants have different capacities to phosphorylate these substrates. This would be revealed by the existence of outliers from the curves derived from comparisons of the relative output capabilities of the different mutants (Figure 6), as well as an inability to align the values derived from the dosage response curve for the FUS3 kss1
strain with those of the mutants.
We do not find a strict correlation between the level of Ste12p activation and the other outputs, suggesting that Fus3p phosphorylates multiple effectors in addition to Ste12p to mediate G1 arrest, morphogenesis, and shmoo formation. This is shown in two different ways: by comparing the level of FUS1 expression at which the FUS3 kss1
strain mediates the other outputs to that of the mutants, and by the existence of outliers in the correlative graphs in Figure 6AC. First, it is not possible to align the values of the dosage response curve with respect to FUS1 expression. Many fus3 point mutants undergo some G1 arrest, morphogenesis, and shmoo formation despite greatly reduced levels of FUS1 expression (Table 2), although the FUS3 kss1
strain only mediates these outputs at
-factor levels that induce maximal FUS1 expression (Figure 4). In addition, mutants with the same level of FUS1 expression can have varying capacities to promote G1 arrest (Figure 6A, compare the G1 arrest capacities of mutants with ~20% wild-type levels of FUS1 mRNA). Second, two classes of outliers are found when the mutants are compared among themselves for all three outputs (Figure 6, AC). Class I outliers constitute mutants with a greater than expected ability to promote either G1 arrest, morphogenesis, or shmoo formation (solid triangles to the right of the curves in Figure 6, AC), while class II outliers constitute mutants with greater-than-expected defects in either G1 arrest, morphogenesis, or shmoo formation for their relative levels of FUS1 expression (solid triangles above the curves in Figure 6, AC). The absence of correlation is not explained by aberrant expression of the FUS1 gene because the mutants express essentially wild-type levels of another Ste12p-dependent gene, FAR1 (![]()
![]()
-factor (Figure 5; Table 3). Taken together, these findings argue for a direct role for Fus3p in mediating all three outputs, and they suggest that other aspects of Fus3p function distinct from transcriptional activation of Ste12p also mediate G1 arrest, morphogenesis, and shmoo formation.
Remarkably, the fus3 mutations that constitute each class of outliers are predicted to have similar functional consequences on Fus3p. Class I outliers are all predicted to have defects in enzymatic activity or in their ability to be activated by Ste7p (fus3-203, fus3-204, fus3-206, and fus3-213), while class II outliers are all predicted to be defective in interactions with substrates (fus3-207, fus3-208, fus3-209, and fus3-210). Class I outliers may have alterations in the absolute level of Fus3p kinase activity or the duration of the period of Fus3p activation. The enhanced capability of the fus3-204 mutant to undergo G1 arrest, enlarge, and form projections raises the possibility that this is a gain-of-function mutation. Class II outliers are most likely to have reduced capability to bind to substrates involved in G1 arrest, morphogenesis, and shmoo formation while maintaining greater affinity for binding to substrate(s) involved in transcriptional activation (such as Ste12p). Curiously, an increasing number of class II outliers are found for G1 arrest (fus3-207 and fus3-210), morphogenesis (fus3-207, fus3-208, and fus3-210), and shmoo formation (fus3-207, fus3-208, fus3-209, and fus3-210), respectively, perhaps reflecting increasing constraints for binding to substrates in these outputs.
Optimal shmoo formation strongly correlates with G1 arrest:
The fact that the mutants were originally selected on the basis of
-factor resistance and are most defective in morphogenesis and shmoo formation (Table 2) raises the possibility that G1 arrest and morphogenesis responses are connected. This possibility is strongly supported by correlative analysis (Figure 6, DE). The most striking correlation is found for shmoo formation (Figure 6E). Here, optimal shmoo formation is achieved only in the strains that undergo wild-type levels of G1 arrest. Moreover, a nearly superimposable curve is found using the values from the dose response curve of the FUS3 kss1
strain (squares), substantiating the findings with the fus3 point mutants. These relationships strongly suggest that shmoo formation is linked to prior G1 arrest.
Mating capacity of fus3 mutants does not strictly correlate with ability to activate Ste12, promote G1 arrest, or form shmoos:
Because Ste12p function is critical for mating (![]()
strains that exhibit varying levels of transcription, G1 arrest, and shmoo formation (Table 2). A critical dosage of Fus3p function that pertains to Ste12p-dependent transcription is essential for mating. The fus3R42R43 kss1
strain with the lowest levels of FUS1 expression is nearly as defective in mating as the fus3
kss1
double-null mutant, while the fus3-205 kss1
strain with somewhat higher levels of expression (18% wild type) is 36-fold defective in mating, and the fus3-209 kss1
strain with high levels of FUS1 expression (95% wild type) mates efficiently.
As with the other outputs, however, transcriptional activation of FUS1 is not always a predictor of mating capacity. For example, the fus3
KSS1 strain has a 250,000-fold defect in mating, even though Kss1p induces FUS1 to 46% wild-type levels. By contrast, fus3-2 kss1
, fus3-206 kss1
, fus3-211 kss1
, and fus3-212 kss1
strains have much more modest defects in mating despite equivalent or lower levels of FUS1 transcription than in a fus3
KSS1 strain. Furthermore, mating ability does not correlate with either G1 arrest or shmoo formation (Table 2). Thus, Fus3p appears to have mating functions that are independent of G1 arrest, activation of Ste12p, and shmoo formation and for which Kss1p cannot be substituted. This view is consistent with a specific requirement for Fus3p in cell fusion (![]()
Fus3p promotes partner selection by a distinct mechanism:
During the course of this analysis, we discovered that bar1
and fus3
null mutations cause synthetic sterility (Table 2 and legend). The synthetic sterility with bar1
suggests that Fus3p is required for chemotropic partner selection, a process that involves orienting the projection toward the pheromone gradient produced by a candidate partner cell (![]()
![]()
![]()
-factor, while that of the bar1
null is only somewhat inhibited as a result of a partner selection defect (Table 6). The fus3
KSS1 null mutant is nearly insensitive to the added
-factor (only 1.9-fold inhibition), indicating that Fus3p is required for partner selection. The fus3
bar1
double mutant is more defective in partner selection than either single mutant, suggesting that Fus3p regulates partner selection by a different mechanism than does Bar1p. [The fus3
bar1
strain mates much better in this liquid mating assay than it does in the solid mating assay (Table 2). Further work is needed to determine why this is so.] Because the fus3 null behaves like a far1 null in the confusion assay (![]()
![]()
and sst2
mutants.
|
We measured partner selection in a subset of fus3 kss1
bar1
strains with varying levels of transcription, G1 arrest, and shmoo formation to determine whether their ability to mate better than a fus3
KSS1 bar1
strain correlates with better partner selection (Table 7). Three of these strains (fus3-2, fus3-209, and fus3-213) are as defective as the fus3
KSS1 strain, suggesting that their mating capacity does not result from better partner selection. The fus3-204 kss1
bar1
strain, however, chooses partners more efficiently than the fus3
KSS1 bar1
strain, nearly as well as a FUS3 kss1
bar1
strain. The enhanced partner selection correlates with enhanced shmoo and mating capabilities (Table 2 and Table 6). Thus, Fus3p may regulate partner selection by a mechanism that is distinct from transcriptional activation and G1 arrest but possibly related to shmoo formation.
|
KSS1 suppresses the fus3 point mutants to varying degrees and contributes to shmoo formation in the presence of Fus3p:
Comparative analysis of fus3 kss1
and fus3
KSS1 strains shows that Kss1p is unable to substitute for Fus3p for essential functions in partner selection and mating (Table 2 and Table 6). To assess the relative contribution of Kss1p in other outputs, we examined whether the KSS1 gene suppresses G1 arrest, and transcriptional and morphological defects of the fus3 point mutants. Kss1p restores more efficient transcription of the FUS1 gene, G1 arrest, and shmoo formation to most of the mutants (Table 3 and Table 7, compare fus3 kss1
and fus3 KSS1 strains). In most instances, FUS1 transcription, G1 arrest, and shmoo formation are not restored to the level of a FUS3 KSS1 strain, although all of the fus3 alleles (except fus3R42R43) have partial function. This result is consistent with the fact that Kss1p does not fully substitute for Fus3p for activation of Ste12p (![]()
![]()
Two additional observations support the view that Kss1p helps to promote multiple outputs in a wild-type strain. First, Kss1p fully suppresses the defects in G1 arrest and shmoo formation of fus3-211 and fus3-212 mutants while only partially suppressing their transcription defects (Table 7). The more efficient suppression of the outputs requiring more signaling is noteworthy because it suggests that Kss1p provides G1 arrest and shmoo formation functions to mutants that are more selectively defective in activation of Ste12p. Second, assessment of kss1
and KSS1 strains shows that Kss1p is required for efficient shmoo formation (Table 5, compare FUS3 KSS1-73%, FUS3 kss1
-34%, average of triplicate experiments). Taken together, these data suggest that, while Kss1p is unable to provide essential functions for partner selection and mating in a wild-type strain, it does partially contribute to the activation of Ste12p, G1 arrest, and shmoo formation.
Many of the fus3 mutants promote recovery:
Surprisingly, seven fus3 kss1
strains undergo efficient G1 arrest (fus3-203, fus3-204, fus3-206, fus3-208, fus3-209, and fus3-213) despite the fact that they are
-factor resistant in a halo assay (Table 2). Because the amount of growth in a halo assay is the sum of G1 arrest and recovery processes, the
-factor resistance of these strains could result from an enhanced ability to promote recovery. The fus3-2 mutant may also have an increased ability to recover, on the basis of the observation that KSS1 restores better G1 arrest to the fus3-2 strain (87% wild-type arrest capacity, Table 4), but it does not restore
-factor sensitivity in a halo assay (data not shown). Interestingly, the arrest-competent,
-factor-resistant fus3 alleles fall into two classes with respect to Ste7p phosphorylation (Table 2): those with wild-type activity (fus3-206, fus3-209, and fus3-213) and those with reduced activity (fus3-2, fus3-203, fus3-204, and fus3-208). While the use of Ste7p as a substrate may underestimate a catalytic defect, this raises the possibility that Fus3 promotes recovery through two mechanisms, one that requires catalytic activity and one that does not.
To test whether Fus3p promotes recovery through a mechanism distinct from G1 arrest, we analyzed the kinetics of arrest and recovery for a mutant from each class (fus3-206 and fus3-208) in addition to fus3-2. Logarithmically growing cells were treated with 25 nM
-factor, and the percentage of unbudded cells was monitored during a period of 9 hr. As shown in Figure 7, all three fus3 kss1
strains recover from G1 arrest more rapidly than the FUS3 kss1
strain. The FUS3 kss1
strain is maximally arrested after 2 hr in
-factor and begins to recover 45 hr later, as shown by the drop in the percentage of unbudded cells. In contrast, the fus3 mutants begin to recover within 12 hr of their maximal arrest time points, leading to more budded cells at the 9-hr time point. Thus, at least three fus3 alleles encode proteins that promote faster recovery. These data argue that Fus3p promotes recovery by a mechanism that is distinct from its ability to promote G1 arrest.
|
Catalytically inactive Fus3p inhibits the function of both Fus3p and Kss1p:
It has been argued that catalytically inactive forms of Fus3p interfere solely with the function of Kss1p, with no effect on Fus3p (![]()
![]()
We first tested whether catalytically inactive Fus3p inhibits the function of Fus3p by comparing the expression of FUS1-lacZ in FUS3 KSS1, FUS3 kss1
, and fus3
KSS1 strains harboring the catalytically inactive fus3R42R43 gene on a CEN plasmid. As shown in Table 8, fus3R42R43 inhibits
-factor-dependent activation of FUS1-lacZ in both FUS3 strains, in addition to inhibiting expression in the fus3
KSS1 strain. Furthermore, fus3R42R43 causes nearly the same level of inhibition in both FUS3 KSS1 and FUS3 kss1
strains, indicating that the major target of inhibition in a wild-type strain is FUS3 rather than KSS1. fus3Y182F and fus3T180A also inhibit FUS1 expression in FUS3 KSS1 and FUS3 kss1
strains (monitored by a FUS1-HIS3 reporter gene, data not shown), indicating that the unactivated form of Fus3p is also inhibitory. Thus, catalytically impaired Fus3p preferentially inhibits the function of Fus3p compared to Kss1p, providing a possible explanation for the enhanced recovery of fus3 mutants with reduced catalytic activity.
|
Catalytically inactive Fus3p hastens recovery but does not block G1 arrest or shmoo formation:
We next tested whether catalytically inactive Fus3p promotes recovery in the presence of wild-type Fus3p and Kss1p by determining whether the fus3R42R43 centromere plasmid causes a wild-type strain to become
-factor resistant in a halo assay and recover faster in an
-factor time course experiment. FUS3 KSS1 and FUS3 kss1
strains harboring the fus3R42R43 gene are more resistant to
-factor, as shown by turbid halos (Figure 8A). Slightly greater resistance is found for the FUS3 kss1
strain, which is consistent with the greater inhibition of FUS1 expression (Table 8). Figure 8B shows that, while both FUS3 fus3R42R43 and FUS3 strains arrest with identical kinetics and efficiency in the presence of
-factor, the FUS3 fus3R42R43 strain initiates recovery approximately two cell cycles (3 hr) before the FUS3 strain. Furthermore, fus3R42R43 does not inhibit shmoo formation (Figure 8C) despite the lower levels of FUS1 expression. Indeed, a greater number of multishmoo cells accumulate in the presence of fus3R42R43 (Figure 8D), as if fus3R42R43 allows cells to more rapidly reset a program of shmoo formation. Thus, catalytically inactive Fus3p promotes exit from G1 arrest and reentry into the mitotic cycle. In addition, it may promote the formation of a second projection under conditions that preclude exit from G1 arrest.
|
| DISCUSSION |
|---|
Fus3p regulates numerous outputs through distinct functions:
Analysis of the role of Fus3p in mating is complicated by the fact that Fus3p activates the expression of Ste12p-dependent genes involved in many aspects of mating. Thus, any response to mating pheromone attributed to Fus3p could be a secondary consequence of Ste12p activation. Relative output dependencies are not revealed by analysis of a FUS3 kss1
strain, which has maximal FUS1 expression at all levels of G1 arrest and shmoo formation, and maximal G1 arrest at all but the lowest levels of morphogenesis and shmoo formation. Through a comparative analysis of a panel of fus3 point mutants, however, we find functional evidence in favor of a model in which Fus3p regulates G1 arrest, shmoo formation, partner selection, mating, and recovery through the phosphorylation of distinct effectors in addition to Ste12p. Our findings are consistent with initial in vitro analysis suggesting the existence of numerous Fus3p substrates (![]()
What determines Fus3p signaling capacity?
Our results suggest that Fus3p dosage may be an important determinant of signaling. A simple view of signal transduction during mating might be one in which different amounts of active Fus3p kinase are needed to execute different responses, given that Fus3p levels increase severalfold in the presence of
-factor (![]()
![]()
-factor are required to elicit transcriptional activation of Ste12p, agglutination, G1 arrest, and shmoo formation, a late response (Figure 4; ![]()
null for G1 arrest only when it is expressed at levels equivalent to the FUS3 gene in the presence of
-factor (F. FARLEY and E. ELION, unpublished results).
One might imagine that certain fus3 mutations cause differential effects on the various outputs as a consequence of a decrease in the overall level of Fus3p kinase activity and preferential phosphorylation of certain substrates. This possibility fits with our correlative data and the predicted structural defects of some of the fus3 mutants. The fact that on average the mutants are less defective in transcription and most defective in shmoo formation suggests that increasing Fus3p function is required for transcriptional activation, G1 arrest, and shmoo formation. This is consistent with the dosage response curves for the FUS3 kss1
strain (Figure 4). It is possible that persistent activation of Fus3p is required to generate the morphogenesis response.
Our analysis also suggests that factors other than the absolute level of kinase activity affect Fus3p function. Several fus3 mutants that are predicted to be defective in interactions with activators and/or substrates exhibit varying defects in the individual outputs (Table 2; Figure 8). Fus3p localizes in the cytoplasm and nucleus (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Fus3p regulates recovery through a mechanism that is distinct from its ability to promote G1 arrest:
Our analysis provides the first functional evidence that Fus3p promotes recovery through a mechanism that is distinct from its ability to promote G1 arrest. This function may involve the phosphorylation of effectors that promote recovery. Several of the fus3 mutants that appear to have enhanced recovery exhibit normal hyperphosphorylation of Ste7p (fus3-206, fus3-209, and fus3-213), indicating that the
-factor resistance in these strains is not caused by a defect in hyperphosphorylation of Ste7p.
Catalytically inactive Fus3p is also likely to promote recovery through the inhibition of active Fus3p and Kss1p. First, catalytically defective mutants can promote
-factor resistance without blocking G1 arrest (e.g., fus3-2, fus3-203, fus3-204, fus3-206, fus3-208, and fus3-209). Second, many catalytically defective mutants were found to inhibit the function of active Fus3p (fus3R42R43) and active Kss1p (fus3R42R43, fus3-2, fus3-205, fus3-206, and fus3-210), as assessed by activation of the FUS1 gene. Third, time course analysis demonstrates that catalytically inactive fus3R42R43 hastens recovery in a FUS3 KSS1 strain without blocking G1 arrest or shmoo formation.
How might catalytically inactive Fus3p promote recovery? The most obvious explanation is that inactive forms of Fus3p bind to and sequester upstream activators or downstream substrates from active Fus3p or Kss1p. Fus3p, rather than Kss1p, is likely to be the major target of inhibition, because catalytically inactive Fus3p inhibits activation of FUS1 in a FUS3 kss1
strain nearly equally as well as in a FUS3 KSS1 strain. Consistent with this possibility, catalytically inactive Fus3p forms stable complexes with both activators and substrates (![]()
![]()
![]()
-factor indicate the existence of a large pool of catalytically inactive Fus3p after 60 min (![]()
Does catalytically inactive Fus3p play a role in the timing of the pheromone response?
Several results raise the possibility that the regulation of G1 arrest by Fus3p may play a role in the timing of a cell's initiation of, and exit from, a program of terminal differentiation. First, the ability of Fus3p to promote shmoo formation was found to be closely linked to its ability to promote G1 arrest. Second, faster recovery may correlate with an ability to form multiple shmoos (see multishmoo tallies for FUS3 KSS1, fus3R42R43, fus3-204 kss1
, and fus3-213 kss1
, Table 5; Figure 8). Our previous work suggests that proteins required for shmoo formation and G1 arrest may colocalize with the MAP kinase cascade and be jointly regulated by Fus3p as well as functionally interdependent (![]()
Kss1p is likely to phosphorylate a subset of the same substrates as Fus3p:
The suppression analysis suggests that, in a wild-type strain, Fus3p performs the bulk of phosphorylation of effector proteins in the mating signaling cascade, with Kss1p playing a much less critical role for many outputs. This view is consistent with earlier analyses (![]()
![]()
![]()
![]()
![]()
kss1
double-null mutant (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We thank R. Tung for constructing the fus3R42R43 mutant, F. Walker for technical assistance during the early stages of this work, B. Errede for pNC318 (Ste7Mp), and J. Wilsbacher for help with structural analysis of the fus3 mutants. We also thank an anonymous reviewer for very useful criticisms of the manuscript. This research was supported by a Young Investigator Grant from the Harcourt Charitable Foundation, National Institutes of Health grant RO1GM46962, a grant from the Council for Tobacco Research, an American Cancer Society Junior faculty award to E.A.E., and a predoctoral National Science Foundation Fellowship to B.S.
Manuscript received August 27, 1998; Accepted for publication January 14, 1999.
| LITERATURE CITED |
|---|
BARDWELL, L., J. G. COOK, E. C. CHANG, B. R. CAIRNS, and J. THORNER, 1996 Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein (MAP) kinases Kss1 and Fus3 with the upstream MAP kinase kinase Ste7. Mol. Cell. Biol. 16:3637-3650[Abstract].
BOEKE, J. D., J. TRUEHEART, G. NATSOULIS, and G. R. FINK, 1984 A positive selection for mutants lacking orotidine 5'-phosphate decarboxylase activity in yeast: 5-fluoroorotic acid resistance. Mol. Gen. Genet. 1818:288-291.
BOULTON, T. G., G. D. YANCOPOULOS, J. S. GREGORG, C. SLAUGHTER, and C. MOOMAN et al., 1990 An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64-67
BRILL, J. A., E. A. ELION, and G. R. FINK, 1994 A role for autophosphorylation revealed by activated alleles of FUS3, the yeast MAP kinase homolog. Mol. Biol. Cell 5:297-312[Abstract].
BRUNET, A. and J. POUYSSEGUR, 1996 Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science 272:1652-1655[Abstract].
CANAGARAJAH, B., A. KHOKHLATCHEV, M. H. COBB, and E. J. GOLDSMITH, 1997 The structure of phosphorylated MAP kinase Erk2p at 2.5 Å resolution. Cell 90:859-869[Medline].
CHANG, F. and I. HERSKOWITZ, 1990 Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of the G1 cyclin CLN2. Cell 63:999-1011[Medline].
CHERKASOVA, V., D. M. LYONS, and E. A. ELION, 1999 Fus3p and Kss1p control G1 arrest in Saccharomyces cerevisiae through a balance of distinct arrest and proliferative functions that operate in parallel with Far1p. Genetics 151:989-1004
CHOI, K.-Y., B. SATTERBERG, D. M. LYONS, and E. A. ELION, 1994 Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae.. Cell 78:499-512[Medline].
CHOI, K.-Y., J. E. KRANZ, S. K. MAHANTY, and E. A. ELION, 1999 Characterization of Fus3 localization: active Fus3 localizes in complexes of varying size and specific activity. Mol. Biol. Cell in press.
CIEJEK, E. and J. THORNER, 1979 Recovery of S. cerevisiae a cells from G1 arrest by
-factor requires endopeptidase action. Cell 18:623-635[Medline].
COOK, J. G., L. BARDWELL, S. J. KRON, and J. THORNER, 1996 Two novel targets of the MAP kinase Kss1 are negative regulators of invasive growth in the yeast Saccharomyces cerevisiae.. Genes Dev. 10:2831-2848
COURCHESNE, W. E., R. KUNISAWA, and J. THORNER, 1989 A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiae.. Cell 58:1107-1119[Medline].
CRAVEN, G. R., E. J. STEERS, J. L. BETHUNE, and C. B. ANFINSEN, 1965 Purification, composition, and molecular weight of the ß-galactosidase of Escherichia coli K12. J. Biol. Chem. 240:2468-2477
DORER, R., P. M. PRYCIAK, and L. H. HARTWELL, 1995 Saccharomyces cerevisiae cells execute a default pathway to select a mate in the absence of pheromone gradients. J. Cell Biol. 131:845-861
DORER, R., C. BOONE, T. KIMBROUGH, J. KIM, and L. H. HARTWELL, 1997 Genetic analysis of default mating behavior in Saccharomyces cerevisiae.. Genetics 146:39-55[Abstract].
ELION, E. A., 1995 Ste5: a meeting place for MAP kinases and their associates. Trends Cell Biol. 5:322-327[Medline].
ELION, E. A. and J. R. WARNER, 1986 An RNA polymerase I enhancer in Saccharomyces cerevisiae.. Mol. Cell. Biol. 6:2089-2097
ELION, E. A., P. GRISAFI, and G. R. FINK, 1990 FUS3 encodes a cdc2/CDC28-related kinase required for the transition from mitosis into conjugation. Cell 60:649-664[Medline].
ELION, E. A., J. A. BRILL, and G. R. FINK, 1991a Functional redundancy in the yeast cell cycle: FUS3 and KSS1 have both overlapping and unique functions. Cold Spring Harbor Symp. Quant. Biol. 56:41-49
ELION, E. A., J. A. BRILL, and G. R. FINK, 1991b FUS3 represses CLN1 and CLN2 and in concert with KSS1 promotes signal transduction. Proc. Natl. Acad. Sci. USA 88:9392-9396
ELION, E. A., B. SATTERBERG, and J. E. KRANZ, 1993 Fus3 phosphorylates multiple components of the mating signal transduction cascade: evidence for Ste12 and Far1. Mol. Biol. Cell 5:495-510.
ELION, E. A., J. TRUEHEART, and G. R. FINK, 1995 Fus2 localizes near the site of cell fusion and is required for both cell fusion and nuclear alignment during zygote formation. J. Cell Biol. 130:1283-1296
ERREDE, B., A. GARTNER, Z. ZHOU, K. NASMYTH, and G. AMMERER, 1993 MAP kinase-related FUS3 from S. cerevisiae is activated by STE7 in vitro.. Nature 362:261-264[Medline].
FENG, Y., L. Y. SONG, E. KINCAID, S. K. MAHANTY, and E. A. ELION, 1998 Functional binding between Gß and the LIM domain of Ste5 is required to activate the MEKK Ste11. Curr. Biol. 8:267-278[Medline].
GARTNER, A., K. NASMYTH, and G. AMMERER, 1992 Signal transduction in Saccharomyces cerevisiae requires tyrosine and threonine phosphorylation of FUS3 and KSS1. Genes Dev. 6:1280-1292
GIETZ, R. D. and A. SUGINO, 1988 New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74:527-534[Medline].
HERSKOWITZ, I., 1995 MAP kinase pathways in yeast: for mating and more. Cell 80:187-197[Medline].
HOFFMAN, C. S. and F. WINSTON, 1987 A ten minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of E. coli.. Gene 57:267-272[Medline].
ITO, H., Y. FUKADA, K. MURATA, and A. KIMURA, 1983 Transformation of intact yeast cells with alkali cations. J. Bacteriol. 153:163-168
KALLUNKI, T., B. SU, I. TSIGELNY, H. K. SLUSS, and B. DERIJARD et al., 1994 JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:2996-3007
KRANZ, J. E., B. SATTERBERG, and E. A. ELION, 1994 The MAP kinase Fus3 associates with and phosphorylates the upstream signaling component Ste5. Genes Dev. 8:313-327
LEBERER, E., D. DIGNARD, D. HARCUS, D. Y. THOMAS, and M. WHITEWAY, 1992 The protein kinase homolog Ste20 is required to link the yeast pheromone response G-protein ß
subunits to downstream signaling components. EMBO J. 11:4815-4824[Medline].
LEEUW, T., A. FOUREST-LIEUVIN, C. WU, J. CHENEVERT, and K. CLARK et al., 1995 Pheromone response in yeast: association of Bem1 with proteins of the MAP kinase cascade and actin. Science 270:1210-1213
LYONS, D. M., S. K. MAHANTY, K.-Y. CHOI, M. MANANDHAR, and E. A. ELION, 1996 The SH3-domain protein Bem1 coordinates MAP kinase cascade activation with cell cycle control. Mol. Cell. Biol. 16:4095-4106[Abstract].
MA, D., J. G. COOK, and J. THORNER, 1995 Phosphorylation and localization of Kss1, a MAP kinase of the Saccharomyces cerevisiae pheromone response pathway. Mol. Biol. Cell 6:889-909[Abstract].
MADHANI, H. D., C. A. STYLES, and G. R. FINK, 1997 MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation. Cell 91:685-694[Medline].
MCCAFFREY, G., F. J. CLAY, K. KELSAY, and G. F. SPRAGUE, JR., 1987 Identification and regulation of a gene required for cell fusion during mating of the yeast Saccharomyces cerevisiae.. Mol. Cell. Biol. 7:2680-2690
MOORE, S. A., 1983 Comparison of dose-response curves for
-factor-induced cell division arrest, agglutination, and projection formation of yeast cells. J. Biol. Chem. 258:13849-13853
NEIMAN, A. M. and I. HERSKOWITZ, 1994 Reconstitution of a yeast protein kinase cascade in vitro: activation of the yeast MEK homologue STE7 by STE11. Proc. Natl. Acad. Sci. USA 91:3398-3402
OEHLEN, L. J. W. M., J. D. MCKINNEY, and F. R. CROSS, 1996 Ste12p and Mcm1 regulate cell cycle-dependent transcription of FAR1. Mol. Cell. Biol. 16:2830-2837[Abstract].
PETER, M., A. GARTNER, J. HORECKA, G. AMMERER, and I. HERSKOWITZ, 1993 FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73:747-760[Medline].
RAMER, S. A. and R. W. DAVIS, 1993 A dominant truncation allele identifies a gene, STE20, that encodes a putative protein kinase necessary for mating in Saccharomyces cerevisiae.. Proc. Natl. Acad. Sci. USA 90:452-456
SAMBROOK, J., E. F. FRITSCH and T. MANIATIS, 1989 Molecular Cloning: A Laboratory Manual, Ed. 2, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SATTERBERG, B., 1993 G1 cell cycle arrest in S. cerevisiae, Ph.D. Thesis. Harvard University, Cambridge, MA.
SHERMAN, F., G. R. FINK and J. B. HICKS, 1986 Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
SIMON, M., C. DE VIRGILIO, B. SOUZA, J. R. PRINGLE, and A. ABO et al., 1995 Role for the Rho-family GTPase Cdc42 in yeast mating pheromone signal pathway. Nature 376:702-705[Medline].
SONG, O., J. W. DOLAN, Y. O. YUAN, and S. FIELDS, 1991 Pheromone-dependent phosphorylation of the yeast STE12 protein correlates with transcriptional activation. Genes Dev. 5:741-750
SPRAGUE, G. F., JR., and J. W. THORNER, 1992 Pheromone response and signal transduction during the mating process of Saccharomyces cerevisiae. pp. 657744 in The Molecular and Cellular Biology of the Yeast Saccharomyces, edited by E. JONES, J. PRINGLE and J. BROACH. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
STEVENSON, B. J., N. RHODES, B. ERREDE, and G. F. SPRAGUE, JR., 1992 Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of the G protein. Genes Dev. 6:1293-1304
TEDFORD, K., S. KIM, D. SA, K. STEVENS, and M. TYERS, 1997 Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substrates. Curr. Biol. 7:228-238[Medline].
TRUEHEART, J., J. D. BOEKE, and G. R. FINK, 1987 Two genes required for cell fusion during conjugation: evidence for a pheromone-induced surface protein. Mol. Cell. Biol. 7:2316-2328
TYERS, M. and B. FUTCHER, 1993 Far1 and Fus3 link the mating pheromone signal transduction pathway to three G1-phase Cdc28 kinase complexes. Mol. Cell. Biol. 13:5659-5660
VALTZ, N., M. PETER, and I. HERSKOWITZ, 1995 FAR1 is required for oriented polarization of yeast cells in response to mating pheromones. J. Cell Biol. 131:863-873
ZHANG, F., A. STRAND, D. ROBBINS, M. H. COBB, and E. J. GOLDSMITH, 1994 Atomic structure of the MAP kinase Erk2 at 2.3 Å resolution. Nature 367:704-710[Medline].
ZHOU, Z., A. GARTNER, R. CADE, G. AMMERER, and B. ERREDE, 1993 Pheromone-induced signal transduction in Saccharomyces cerevisiae requires the sequential function of three protein kinases. Mol. Cell. Biol. 13:2069-2080
This article has been cited by other articles:
![]() |
A. I. Goranov, M. Cook, M. Ricicova, G. Ben-Ari, C. Gonzalez, C. Hansen, M. Tyers, and A. Amon The rate of cell growth is governed by cell cycle stage Genes & Dev., June 15, 2009; 23(12): 1408 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Taylor, D. Falconnet, A. Niemisto, S. A. Ramsey, S. Prinz, I. Shmulevich, T. Galitski, and C. L. Hansen Dynamic analysis of MAPK signaling using a high-throughput microfluidic single-cell imaging platform PNAS, March 10, 2009; 106(10): 3758 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Craven, H. Velez, Y. Cho, C. B. Lawrence, and T. K. Mitchell Anastomosis Is Required for Virulence of the Fungal Necrotroph Alternaria brassicicola Eukaryot. Cell, April 1, 2008; 7(4): 675 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, M. Qi, M. A. Sheff, and E. A. Elion Counteractive Control of Polarized Morphogenesis during Mating by Mitogen-activated Protein Kinase Fus3 and G1 Cyclin-dependent Kinase Mol. Biol. Cell, April 1, 2008; 19(4): 1739 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Esch, Y. Wang, and B. Errede Pheromone-Induced Degradation of Ste12 Contributes to Signal Attenuation and the Specificity of Developmental Fate Eukaryot. Cell, December 1, 2006; 5(12): 2147 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fleissner, S. Sarkar, D. J. Jacobson, M. G. Roca, N. D. Read, and N. L. Glass The so Locus Is Required for Vegetative Cell Fusion and Postfertilization Events in Neurospora crassa Eukaryot. Cell, May 1, 2005; 4(5): 920 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, W. Chen, D. M. Simpson, and E. A. Elion Cdc24 Regulates Nuclear Shuttling and Recruitment of the Ste5 Scaffold to a Heterotrimeric G Protein in Saccharomyces cerevisiae J. Biol. Chem., April 1, 2005; 280(13): 13084 - 13096. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Bruno, F. Tenjo, L. Li, J. E. Hamer, and J.-R. Xu Cellular Localization and Role of Kinase Activity of PMK1 in Magnaporthe grisea Eukaryot. Cell, December 1, 2004; 3(6): 1525 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Staleva, A. Hall, and S. J. Orlow Oxidative Stress Activates FUS1 and RLM1 Transcription in the Yeast Saccharomyces cerevisiae in an Oxidant-dependent Manner Mol. Biol. Cell, December 1, 2004; 15(12): 5574 - 5582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flotho, D. M. Simpson, M. Qi, and E. A. Elion Localized Feedback Phosphorylation of Ste5p Scaffold by Associated MAPK Cascade J. Biol. Chem., November 5, 2004; 279(45): 47391 - 47401. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maleri, Q. Ge, E. A. Hackett, Y. Wang, H. G. Dohlman, and B. Errede Persistent Activation by Constitutive Ste7 Promotes Kss1-Mediated Invasive Growth but Fails To Support Fus3-Dependent Mating in Yeast Mol. Cell. Biol., October 15, 2004; 24(20): 9221 - 9238. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Kusari, D. M. Molina, W. Sabbagh Jr., C. S. Lau, and L. Bardwell A conserved protein interaction network involving the yeast MAP kinases Fus3 and Kss1 J. Cell Biol., January 19, 2004; 164(2): 267 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Blanc and J. Adams Evolution in Saccharomyces cerevisiae: Identification of Mutations Increasing Fitness in Laboratory Populations Genetics, November 1, 2003; 165(3): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and E. A. Elion Nuclear Export and Plasma Membrane Recruitment of the Ste5 Scaffold Are Coordinated with Oligomerization and Association with Signal Transduction Components Mol. Biol. Cell, June 1, 2003; 14(6): 2543 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and H. G. Dohlman Pheromone-dependent Ubiquitination of the Mitogen-activated Protein Kinase Kinase Ste7 J. Biol. Chem., May 3, 2002; 277(18): 15766 - 15772. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Elion The Ste5p scaffold J. Cell Sci., March 13, 2002; 114(22): 3967 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Burchett, A. Scott, B. Errede, and H. G. Dohlman Identification of Novel Pheromone-response Regulators through Systematic Overexpression of 120 Protein Kinases in Yeast J. Biol. Chem., July 6, 2001; 276(28): 26472 - 26478. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Correction
- A corrigendum has been published
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Farley, F. W.
- Articles by Elion, E. A.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Farley, F. W.
- Articles by Elion, E. A.

















